Introduction
Burkholderia cepacia is an aerobic gram negative bacillus found in various aquatic environments. It is classifi ed as 10 serovars, collectively termed as the Burkholderia cepacia complex (BCC). [1] It is an organism of low virulence which causes respiratory disease in patients with cystic fi brosis and various nosocomial infections (NI). NI caused by BCC include blood stream infections (BSI), pneumonias, surgical wound infections and genitourinary tract infections. Outbreaks of NI due to BCC have been commonly reported in literature and generally linked to contamination of various fl uids used in hospitals.
all patients since the chemotherapy medication was highly emetogenic. As a fi rst step, compliance to all infection control protocols was assessed, corrected if so required and made more stringent. Hand hygiene was reinforced, medication preparation and administration was regulated, use of only collapsible/closed intravenous fl uid bags initiated. The process of insertion of ports was reviewed. Microbiologic cultures were taken from environmental surfaces, water, air, laminar air fl ow, hands of the health care staff/surgeons and skin cleaning antiseptics. The entire day care unit was fogged and disinfected. A literature search was conducted and possible sources of infection were identifi ed. Prepared chemotherapy medication, opened and unopened intravenous fl uid bags were cultured. Finally, cultures from all unopened chemotherapy medication and antiemetic vials were also sent.
Results
A total of 13 patients (12 females, one male) had BCC bacteremia during the outbreak that lasted 2 months. The study population included 10 women with breast cancer and 3 others with haematologic malignancy (acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML) and Burkitt's lymphoma one each). The mean period between catheter insertion and development of bacteremia was 65 days (range 2-144 days). All the Burkholderia isolates had identical susceptibility and were sensitive to all commonly used antibiotics such as beta lactams, quinolones, beta lactam beta lactamase inhibitor combinations and carbapenems.
All patients were initiated on appropriate antimicrobial therapy. All survived that episode of bacteremia but 11 required removal of the implanted catheter for clinical resolution. The mean period between culture positivity and removal of catheter was 12 days (range 4-21 days). The tips of all the implanted catheters grew Burkholderia cepacia with antimicrobial sensitivity identical to that isolated from the blood.
Cultures from air, water, laminar fl ow, disinfectants including 2% alcoholic chlorhexidine, 10% aqueous povidone iodine and 70% ethanol were negative. Cultures from the environmental surfaces grew bacillus species. The prepared chemotherapy medication grew Burkholderia cepacia. Cultures of the unopened constituents of prepared chemotherapy medication i.e., intravenous fl uid bags, chemotherapy medication were sterile but granisetron vials grew Burkholderia cepacia. Cultures of the unopened granisetron vials (same batch) were repeatedly positive. The antibiotic susceptibility of the Burkholderia isolates were identical to each other and to those isolated from patients. This indicates that this point source outbreak was due to intrinsic contamination of the antiemetic drug granisetron. The results were communicated to the manufacturer, the brand was withdrawn. There were no further cases.
Discussion
This outbreak of BCC bacteremia was thus conclusively linked to intrinsic contamination of anti emetic drug granisetron. This probably happened during the process of manufacturing. This outbreak caused signifi cant morbidity and increase in treatment costs in cancer patients and considerable anxiety among the treating oncologists in a newly commissioned hospital. There was a delay in determining the source since intrinsic contamination of the unopened vials was not suspected. When the prepared chemotherapy medication bags were culture positive, human error and breach of infection control practices was suspected and there was delay in culturing unopened vials.
Previous BCC bacteremia's have been linked to extrinsic contamination of antiseptics including alcohol/chlorhexidine, multi-dose vials of ringer lactate used as water for injection, and mannitol. [3] [4] [5] Intrinsic contamination of medication causing BCC bacteremias similar to the ones seen in this study has also been reported. These include contamination of ultrasound gel, albuterol solution for nebulisation, water for injection, moisturising body milk and intravenous bromopride. [6] [7] [8] [9] [10] We acknowledge nonavailability of pulse fi eld gel electrophoresis (PFGE) or multilocus sequence typing (MLST) as a limitation in proving clonal relatedness of all isolates. However, identical susceptibility patterns, identifi cation of a single common source and cessation of the outbreak after withdrawing the incriminated medication are reasonable indirect evidence of a common source outbreak. We recommend that all medication vials opened and unopened should be cultured at the outset in the event of a BCC outbreak to detect intrinsic contamination early.
